Indomethacin

*Indometacinum*

For medical students2 min readUpdated 2026-10-10

Indomethacin is one of the most potent nonsteroidal anti-inflammatory drugs (NSAIDs) with an established historical role in clinical pharmacology. It is characterized not only by high anti-inflammatory potency but also by a rapid onset of an antipyretic effect. However, due to a broad spectrum of specific adverse reactions, including neurotoxicity and ulcerogenicity, its administration requires a deep understanding of its mechanisms of action and strict evaluation of indications.

EfficacyOne of the most potent anti-inflammatory agents in its class

OnsetCharacterized by a rapid development of the antipyretic effect

TargetsInhibits COX, phospholipases A and C, and suppresses neutrophils

RisksHigh ulcerogenicity, hemato- and neurotoxicity

Pharmacological Profile and Efficacy

In clinical practice, indomethacin is widely regarded as one of the most potent anti-inflammatory agents among all existing NSAIDs (nonsteroidal anti-inflammatory drugs). Its pharmacological activity aims at rapid and effective suppression of inflammatory processes. An important distinguishing feature of the drug is the rapid onset of its antipyretic effect. Unlike some other agents that reduce body temperature gradually, indomethacin is capable of resolving fever in the shortest possible time. When analyzing its pharmacological properties, it is essential to highlight this specific feature: the drug is characterized by a rapid, rather than delayed, antipyretic action.

Expanded Mechanism of Action

The mechanism of action of indomethacin is considerably broader than that of most standard NSAIDs, which accounts for its outstanding clinical efficacy. The pharmacodynamics of the drug are based on three fundamental processes:

Reversible inhibition of COX (cyclooxygenase). This is the classic pathway: the drug temporarily binds to the enzyme, interrupting arachidonic acid metabolism and halting the synthesis of inflammatory mediators.
Inhibition of phospholipase A and C. This is a unique feature of its expanded mechanism. By blocking these enzymes, the drug acts at additional steps of the inflammatory cascade.
Suppression of neutrophil proliferation. Neutrophils actively participate in sustaining inflammation. Indomethacin inhibits their proliferation, thereby depriving the pathological process of cellular support.

Main Clinical Indications

Due to its high potency and associated risks, indomethacin is prescribed for severe, chronic, or acute systemic disorders of the musculoskeletal system. The primary indications include:

Ankylosing spondylitis (Bechterew's disease) — systemic inflammation of the spinal joints requiring potent anti-inflammatory suppression.
Gout — the drug is effectively used to manage acute attacks of gouty arthritis.
Various rheumatic diseases — a broad spectrum of inflammatory disorders requiring aggressive therapy.

Safety Profile and Adverse Effects

The clinical use of indomethacin is strictly limited by its toxicity. The drug exhibits all typical adverse effects characteristic of the NSAID class, but its main clinical challenge lies in specific risks:

Pronounced ulcerogenic effect: the drug aggressively affects the mucosa, rapidly provoking ulcer formation in the gastrointestinal tract.
Hematological abnormalities: indomethacin can suppress hematopoiesis, manifesting as anemia and leukopenia.
Neurotoxicity: specific negative impact on the central nervous system. Patients frequently experience intense headaches and marked dizziness.

Mnemonic

To easily remember the three specific adverse effects of indomethacin, use the mnemonic GUN: G — Hematological abnormalities (anemia, leukopenia), U — Ulcerogenic effect (ulcer formation), N — Neurotoxicity (headache and dizziness). Association: the drug is so potent that it strikes the body like an invasion of the "Huns".

Frequently asked questions

Which chemical derivative group does indomethacin belong to?

Indomethacin belongs to the acetic acid derivative group, specifically indoleacetic and phenylacetic acids. Its chemical structure contains a specific indole ring. Other nonsteroidal anti-inflammatory drugs, such as diclofenac and ketorolac, also belong to this structural group of acetic acid derivatives.

What are the absolute contraindications for indomethacin?

Absolute contraindications for prescribing indomethacin include gastrointestinal, hematological, and hepatic disorders, as well as pediatric age.

The drug is strictly contraindicated in:

Peptic ulcer disease of the stomach and duodenum;
Blood coagulation disorders and increased bleeding tendency;
Impaired liver function;
Bronchial asthma and hypersensitivity to aspirin;
Age under 14 years (for the oral tablet form).

In obstetric practice, the drug is contraindicated in fetal growth restriction and congenital renal anomalies in the fetus.

What gastrointestinal side effects does indomethacin cause?

Gastrointestinal adverse effects include:

Pronounced ulcerogenic effect (ulcer formation) and erosive-ulcerative lesions of the stomach;
Gastrointestinal bleeding;
Nausea;
Gastritis;
Reflux esophagitis.

The peak risk of developing erosive and ulcerative lesions during indomethacin therapy occurs around days 7–14.

With which drugs does indomethacin enter into clinically significant interactions?

Indomethacin suppresses steroid formation, thereby reducing the anxiolytic effect of certain tranquilizers whose action on GABA receptors is linked to the stimulation of endogenous steroid synthesis. An example of such a drug is etifoxine.

In what dosage forms is indomethacin available?

Oral and rectal administration routes are indicated for indomethacin. Tablets are taken orally; rectal administration is indicated for a starting dose of 50–100 mg in tocolytic therapy. The specific rectal dosage form is not detailed in the sources.

How fast does the antipyretic effect develop when taking indomethacin?

Indomethacin is characterized by a rapid onset of its antipyretic effect. This is one of its key pharmacodynamic advantages in managing acute conditions.

What is the expanded mechanism of action of this drug?

In addition to standard reversible inhibition of the COX enzyme, indomethacin additionally blocks phospholipases A and C and directly suppresses neutrophil proliferation.

To which pharmacological group does indomethacin belong, and what side effects are typical for it?

Indomethacin belongs to the NSAID group (nonsteroidal anti-inflammatory drugs). Consequently, it possesses all the adverse effects typical of this class.

What specific risks are associated with indomethacin intake?

Specific risks include a pronounced ulcerogenic effect (ulcer formation), neurotoxicity (severe headache, dizziness), and hematological abnormalities (anemia and leukopenia).

Go deeper

Comparative characteristics of the anti-inflammatory potency of indomethacin versus other NSAIDs.
Biochemical role of phospholipase A and C in the arachidonic acid cascade.
Pathogenesis of ulcerogenic effects during systemic COX inhibition.
Mechanisms of neurotoxicity associated with indoleacetic acid derivatives.
Protocols for indomethacin use in acute gout attacks and ankylosing spondylitis.